Kevin Lee, PA
Physician Assistant · Salinas
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 4
Offices
4 locations · Csi Medical Group · 104 clinicians in this group
Looking this up.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Kevin Lee’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A63162 · Current
Licensed to practise in California · since 1997 · expires 2028-09-30 · Louisiana State University School of Medicine in Shreveport.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$143,007
Medicare paid this office $143,007 for 833 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 414 | $32,359 | $60 |
| New patient visit (30+ min) | 366 | $23,490 | $64 |
| Destruction of skin growth, 1-14 growths | 179 | $15,000 | $79 |
| Biopsy of related skin growth, first growth | 202 | $14,064 | $64 |
| Destruction of precancer skin growth, 1 growth | 212 | $10,200 | $38 |
See all 18 services
| Short return visit (20+ min) | 414 | $32,359 | $60 |
| New patient visit (30+ min) | 366 | $23,490 | $64 |
| Destruction of skin growth, 1-14 growths | 179 | $15,000 | $79 |
| Biopsy of related skin growth, first growth | 202 | $14,064 | $64 |
| Destruction of precancer skin growth, 1 growth | 212 | $10,200 | $38 |
| Return visit (30+ min) | 75 | $8,241 | $84 |
| New patient visit (45+ min) | 50 | $5,599 | $112 |
| Destruction of precancer skin growth, 2-14 growths | 149 | $4,087 | $5 |
| Biopsy of related skin growth, each additional growth | 65 | $3,204 | $36 |
| Destruction of precancer skin growth, 15 or more growths | 18 | $2,132 | $118 |
| Simple or single drainage of skin abscess | 18 | $1,624 | $90 |
| Punch biopsy, first skin growth | 12 | $1,172 | $98 |
| Injection into skin growth, 1-7 growths | 19 | $1,146 | $37 |
| Short return visit | 20 | $815 | $41 |
| Biopsy of ear | 11 | $518 | $47 |
| New patient visit (15+ min) | 11 | $355 | $32 |
| Injection of drug or substance under skin or into muscle | 11 | $312 | $9 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 20 | $26 | None |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of skin lesions | 1093 | More than 94% of doctors who do this |
| Removal or shaving of skin growth | 46 | More than 78% of doctors who do this |
| Skin biopsy | 226 | More than 87% of doctors who do this |
Who their Medicare patients are
833 Original Medicare patients in 2024. Average age 73 · Under 65 10% · 85 and older 13% · Women 55% · Also on Medicaid 35% · Health risk score 1.13. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 75% · Diabetes 39% · Coronary heart disease 20% · Chronic kidney disease 20% · Depression 16% · Atrial fibrillation 15% · Heart failure 14% · Cancer 12% · COPD 9% · Dementia 6% · Stroke 6%.
The office billed $424,135, Medicare allowed $199,285 and paid $143,007; for 2,962 services of 55 kinds; $645 of it was for drugs given in the office and $142,362 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 833 | 2,962 | 73 | 1.13 | $424,135 | $143,007 |
| 2023 | 208 | 546 | 73 | 1.00 | $96,675 | $29,189 |
| 2022 | 202 | 696 | 74 | 0.96 | $122,645 | $27,351 |
| 2021 | 240 | 694 | 72 | 1.14 | $91,684 | $33,740 |
| 2020 | 44 | 93 | 74 | 1.11 | $14,670 | $4,575 |
| 2019 | 12 | 36 | 71 | 0.79 | $5,145 | $1,731 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| New patient visit (30+ min) | 78 | $5,199 | $67 |
| Short return visit (20+ min) | 76 | $5,116 | $63 |
| Destruction of skin growth, 1-14 growths | 28 | $2,180 | $78 |
| Biopsy of related skin growth, first growth | 30 | $1,978 | $64 |
| Destruction of precancer skin growth, 1 growth | 41 | $1,537 | $34 |
| Destruction of precancer skin growth, 15 or more growths | 11 | $1,417 | $129 |
| Return visit (30+ min) | 11 | $1,048 | $95 |
| Short return visit | 22 | $979 | $41 |
| Destruction of precancer skin growth, 2-14 growths | 28 | $575 | $5 |
2022: 7 services
| Short return visit (20+ min) | 110 | $8,001 | $59 |
| New patient visit (30+ min) | 53 | $3,182 | $60 |
| Destruction of skin growth, 1-14 growths | 27 | $2,115 | $71 |
| Biopsy of related skin growth, first growth | 27 | $1,999 | $67 |
| Destruction of precancer skin growth, 1 growth | 35 | $1,436 | $33 |
| Short return visit | 30 | $1,200 | $34 |
| Destruction of precancer skin growth, 2-14 growths | 24 | $884 | $5 |
2021: 8 services
| Short return visit (20+ min) | 130 | $9,885 | $63 |
| New patient visit (30+ min) | 76 | $5,363 | $71 |
| Biopsy of related skin growth, first growth | 37 | $2,806 | $68 |
| Destruction of skin growth, 1-14 growths | 31 | $2,587 | $76 |
| Short return visit | 30 | $1,328 | $38 |
| Destruction of precancer skin growth, 1 growth | 28 | $1,232 | $37 |
| New patient visit (15+ min) | 14 | $559 | $40 |
| Destruction of precancer skin growth, 2-14 growths | 14 | $274 | $4 |
2020: 2 services
| Return visit (30+ min) | 18 | $1,249 | $69 |
| Short return visit (20+ min) | 15 | $917 | $51 |
Medicaid work
$6,870 in 2021
Medicaid paid $6,870 for 137 billed services this clinician did in 2021, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 79 | $3,511 |
| New patient visit (30+ min) | 58 | $3,359 |
| 2021 | 137 | 2 | 17 | $6,870 |
Drugs they prescribed that Part D paid
$665,228
Pharmacies billed $665,228 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,068) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
967 generic and 101 brand-name prescriptions · $665,228 in drug cost · 66 antibiotic prescriptions to 27 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Skyrizi | 13 | $274,616 | $21,124 |
| Dupixent | 22 | $104,282 | $4,740 |
| Tacrolimus | 30 | $6,281 | $209 |
| Clobetasol Propionate | 120 | $4,970 | $41 |
| Fluorouracil | 58 | $3,778 | $65 |
See all 20 drugs
| Skyrizi | 13 | $274,616 | $21,124 |
| Dupixent | 22 | $104,282 | $4,740 |
| Tacrolimus | 30 | $6,281 | $209 |
| Clobetasol Propionate | 120 | $4,970 | $41 |
| Fluorouracil | 58 | $3,778 | $65 |
| Calcipotriene | 12 | $3,141 | $262 |
| Ketoconazole | 143 | $2,168 | $15 |
| Fluocinonide | 37 | $1,875 | $51 |
| Triamcinolone Acetonide | 134 | $1,621 | $12 |
| Metronidazole | 31 | $1,189 | $38 |
| Betamethasone Diprop Augmented | 33 | $1,083 | $33 |
| Betamethasone Dipropionate | 26 | $1,059 | $41 |
| Desonide | 17 | $1,016 | $60 |
| Doxycycline Hyclate | 59 | $764 | $13 |
| Hydroxyzine | 35 | $439 | $13 |
| Clindamycin Phosphate | 20 | $430 | $21 |
| Ciclopirox | 14 | $269 | $19 |
| Mometasone Furoate | 12 | $254 | $21 |
| Hydrocortisone | 62 | $241 | $4 |
| Mupirocin | 31 | $195 | $6 |
Year by year
| 2024 | 1,068 | 374 | 0% (0) | 9% | $665,228 |
| 2023 | 423 | 180 | 0% (0) | 7% | $101,238 |
| 2022 | 582 | 184 | 0% (0) | 8% | $165,035 |
| 2021 | 596 | 220 | 0% (0) | 11% | $161,061 |
| 2020 | 61 | 32 | 0% (0) | None | $24,361 |
| 2019 | 12 | None | 0% (0) | None | $506 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Clobetasol Propionate | 44 | $3,116 | $71 |
| Ketoconazole | 64 | $2,105 | $33 |
| Fluocinonide | 21 | $1,392 | $66 |
| Metronidazole | 14 | $913 | $65 |
| Betamethasone Diprop Augmented | 25 | $849 | $34 |
| Betamethasone Dipropionate | 11 | $706 | $64 |
| Triamcinolone Acetonide | 51 | $532 | $10 |
| Mometasone Furoate | 18 | $450 | $25 |
| Doxycycline Hyclate | 11 | $258 | $23 |
| Mupirocin | 23 | $228 | $10 |
2022: 17 drugs
| Dupixent | 11 | $37,170 | $3,379 |
| Calcipotriene | 12 | $4,316 | $360 |
| Tretinoin | 20 | $3,617 | $181 |
| Ketoconazole | 66 | $3,035 | $46 |
| Clobetasol Propionate | 69 | $2,857 | $41 |
| Fluocinonide | 21 | $2,478 | $118 |
| Betamethasone Diprop Augmented | 35 | $2,166 | $62 |
| Triamcinolone Acetonide | 69 | $1,239 | $18 |
| Mometasone Furoate | 26 | $644 | $25 |
| Clindamycin Phosphate | 16 | $613 | $38 |
| Desonide | 11 | $607 | $55 |
| Nystatin | 24 | $460 | $19 |
| Doxepin | 12 | $439 | $37 |
| Mupirocin | 38 | $361 | $10 |
| Hydrocortisone | 18 | $116 | $6 |
| Hydroxyzine | 14 | $90 | $6 |
| Prednisone | 12 | $57 | $5 |
2021: 14 drugs
| Otezla | 11 | $43,474 | $3,952 |
| Tacrolimus | 13 | $5,197 | $400 |
| Clobetasol Propionate | 56 | $2,235 | $40 |
| Ketoconazole | 59 | $2,213 | $38 |
| Fluocinonide | 24 | $1,557 | $65 |
| Betamethasone Diprop Augmented | 42 | $1,006 | $24 |
| Fluocinolone Acetonide | 13 | $865 | $67 |
| Triamcinolone Acetonide | 68 | $827 | $12 |
| Mometasone Furoate | 29 | $558 | $19 |
| Clindamycin Phosphate | 11 | $553 | $50 |
| Mupirocin | 51 | $403 | $8 |
| Hydroxyzine | 35 | $160 | $5 |
| Hydrocortisone | 18 | $129 | $7 |
| Prednisone | 14 | $39 | $3 |
2020: 1 drug
| Clobetasol Propionate | 12 | $705 | $59 |
Money from drug and device companies
$3,237 in 2025
| 2025 | 19 | 151 | None | $3,237 |
| 2024 | 19 | 159 | None | $3,487 |
| 2023 | 19 | 137 | None | $2,060 |
| 2022 | 21 | 113 | None | $1,634 |
| 2021 | 19 | 104 | None | $1,678 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Regeneron Healthcare Solutions | Dupixent | $454 | 17 payments
|
| Abbvie | Rinvoq | $417 | 23 payments
|
| Janssen Biotech | Tremfya | $338 | 15 payments
|
| Incyte | Opzelura | $304 | 14 payments
|
| Amgen | Otezla | $273 | 10 payments
|
| Arcutis Biotherapeutics | Zoryve | $256 | 13 payments
|
See all 151 published payments
| Abbvie | Meals · 2025-12-30 | Skyrizi | $12 |
| Janssen Biotech | Meals · 2025-12-23 | Tremfya | $9 |
| Arcutis Biotherapeutics | Meals · 2025-12-17 | Zoryve | $6 |
| Organon | Meals · 2025-12-16 | None | $7 |
| Regeneron Healthcare Solutions | Meals · 2025-12-09 | Dupixent | $29 |
| Ucb | Meals · 2025-12-09 | Bimzelx | $12 |
| Incyte | Meals · 2025-12-01 | Opzelura | $15 |
| Pfizer | Meals · 2025-11-27 | Cibinqo | $20 |
| Abbvie | Meals · 2025-11-25 | Skyrizi | $19 |
| ANI Pharmaceuticals | Meals · 2025-11-25 | Purified Cortrophin Gel | $15 |
| Novartis Pharmaceuticals | Meals · 2025-11-24 | Cosentyx | $19 |
| Regeneron Healthcare Solutions | Meals · 2025-11-24 | Dupixent | $7 |
| Incyte | Meals · 2025-11-20 | Opzelura | $10 |
| LEO Pharma | Meals · 2025-11-18 | Anzupgo | $28 |
| Sun Pharmaceutical Industries | Education · 2025-11-13 | None | $100 |
| Janssen Biotech | Meals · 2025-11-11 | Tremfya | $10 |
| Abbvie | Meals · 2025-11-10 | Rinvoq | $12 |
| Incyte | Meals · 2025-11-06 | Opzelura | $21 |
| Pfizer | Meals · 2025-11-04 | Cibinqo | $28 |
| Genzyme | Meals · 2025-11-03 | Dupixent | $34 |
| Pfizer | Meals · 2025-10-31 | Cibinqo | $18 |
| Pfizer | Meals · 2025-10-31 | Cibinqo | $17 |
| Organon | Meals · 2025-10-31 | None | $8 |
| Galderma Laboratories L.P. | Meals · 2025-10-30 | Nemluvio | $8 |
| Amgen | Meals · 2025-10-29 | Otezla | $24 |
| Abbvie | Meals · 2025-10-28 | Skyrizi | $29 |
| Abbvie | Meals · 2025-10-28 | Skyrizi | $10 |
| Regeneron Healthcare Solutions | Meals · 2025-10-28 | Dupixent | $26 |
| Galderma Laboratories L.P. | Meals · 2025-10-23 | Nemluvio | $28 |
| Janssen Biotech | Meals · 2025-10-21 | Tremfya | $12 |
| Ucb | Meals · 2025-10-21 | Bimzelx | $12 |
| Incyte | Meals · 2025-10-16 | Opzelura | $12 |
| Galderma Laboratories L.P. | Meals · 2025-10-03 | Nemluvio | $8 |
| Organon | Meals · 2025-10-03 | Nexplanon | $8 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-02 | Sotyktu | $14 |
| Janssen Biotech | Education · 2025-10-01 | Tremfya | $72 |
| Arcutis Biotherapeutics | Meals · 2025-10-01 | Zoryve | $9 |
| Arcutis Biotherapeutics | Meals · 2025-10-01 | Zoryve | $9 |
| Regeneron Healthcare Solutions | Meals · 2025-09-30 | Dupixent | $10 |
| Ucb | Meals · 2025-09-30 | Bimzelx | $14 |
| Incyte | Meals · 2025-09-30 | Opzelura | $4 |
| Incyte | Meals · 2025-09-30 | Opzelura | $11 |
| Lilly USA | Meals · 2025-09-25 | Taltz | $24 |
| Ucb | Meals · 2025-09-24 | Bimzelx | $12 |
| Janssen Biotech | Meals · 2025-09-23 | Tremfya | $11 |
| Arcutis Biotherapeutics | Meals · 2025-09-23 | Zoryve | $24 |
| Genzyme | Meals · 2025-09-22 | Dupixent | $33 |
| Incyte | Meals · 2025-09-19 | Opzelura | $24 |
| Pfizer | Meals · 2025-09-16 | Cibinqo | $30 |
| Janssen Biotech | Meals · 2025-09-15 | Tremfya | $12 |
| Janssen Biotech | Meals · 2025-09-10 | Tremfya | $11 |
| Lilly USA | Meals · 2025-09-09 | Taltz | $14 |
| Ucb | Meals · 2025-09-09 | Bimzelx | $16 |
| Incyte | Meals · 2025-09-04 | Opzelura | $19 |
| Regeneron Healthcare Solutions | Meals · 2025-09-03 | Dupixent | $15 |
| Regeneron Healthcare Solutions | Education · 2025-09-02 | Dupixent | $96 |
| Incyte | Meals · 2025-09-02 | Opzelura | $16 |
| Galderma Laboratories L.P. | Meals · 2025-08-27 | Nemluvio | $28 |
| Abbvie | Meals · 2025-08-20 | Rinvoq | $29 |
| Amgen | Meals · 2025-08-06 | Otezla | $32 |
| Organon | Meals · 2025-08-05 | None | $25 |
| Abbvie | Meals · 2025-08-04 | Rinvoq | $29 |
| Janssen Biotech | Meals · 2025-07-30 | Tremfya | $3 |
| Janssen Biotech | Meals · 2025-07-30 | Tremfya | $15 |
| Pfizer | Meals · 2025-07-30 | Cibinqo | $21 |
| Janssen Biotech | Meals · 2025-07-29 | Tremfya | $12 |
| Regeneron Healthcare Solutions | Meals · 2025-07-25 | Dupixent | $9 |
| Lilly USA | Meals · 2025-07-24 | Taltz | $28 |
| Novartis Pharmaceuticals | Meals · 2025-07-23 | Cosentyx | $21 |
| Arcutis Biotherapeutics | Meals · 2025-07-22 | Zoryve | $25 |
| Abbvie | Meals · 2025-07-21 | Rinvoq | $9 |
| Galderma Laboratories L.P. | Meals · 2025-07-21 | Nemluvio | $17 |
| Galderma Laboratories L.P. | Meals · 2025-07-17 | Nemluvio | $18 |
| Abbvie | Meals · 2025-07-15 | Rinvoq | $34 |
| Arcutis Biotherapeutics | Meals · 2025-07-14 | Zoryve | $8 |
| Regeneron Healthcare Solutions | Meals · 2025-07-11 | Dupixent | $13 |
| Janssen Biotech | Meals · 2025-07-10 | Tremfya | $11 |
| Ucb | Meals · 2025-07-08 | Bimzelx | $16 |
| Abbvie | Meals · 2025-06-30 | Rinvoq | $23 |
| Arcutis Biotherapeutics | Meals · 2025-06-30 | Zoryve | $10 |
| Novartis Pharmaceuticals | Meals · 2025-06-25 | Cosentyx | $20 |
| Regeneron Healthcare Solutions | Meals · 2025-06-25 | Dupixent | $35 |
| Janssen Biotech | Meals · 2025-06-24 | Tremfya | $112 |
| Janssen Biotech | Meals · 2025-06-19 | Tremfya | $27 |
| Amgen | Meals · 2025-06-18 | Otezla | $24 |
| Lilly USA | Meals · 2025-06-17 | Taltz | $29 |
| Ucb | Meals · 2025-06-17 | Bimzelx | $12 |
| Genzyme | Meals · 2025-06-16 | Dupixent | $27 |
| Abbvie | Meals · 2025-06-11 | Rinvoq | $21 |
| Arcutis Biotherapeutics | Meals · 2025-06-11 | Zoryve | $23 |
| Galderma Laboratories L.P. | Meals · 2025-06-04 | Nemluvio | $27 |
| Abbvie | Meals · 2025-05-13 | Skyrizi | $10 |
| Ucb | Meals · 2025-05-13 | Bimzelx | $11 |
| Arcutis Biotherapeutics | Meals · 2025-05-13 | Zoryve | $15 |
| Regeneron Healthcare Solutions | Meals · 2025-05-12 | Dupixent | $9 |
| Janssen Biotech | Meals · 2025-05-05 | Tremfya | $9 |
| Abbvie | Meals · 2025-05-05 | Skyrizi | $51 |
| Regeneron Healthcare Solutions | Meals · 2025-05-02 | Dupixent | $117 |
| Ucb | Meals · 2025-04-29 | Bimzelx | $9 |
| Regeneron Healthcare Solutions | Meals · 2025-04-28 | Dupixent | $7 |
| Regeneron Healthcare Solutions | Meals · 2025-04-28 | Libtayo | $9 |
| Abbvie | Meals · 2025-04-22 | Skyrizi | $9 |
| Regeneron Healthcare Solutions | Meals · 2025-04-16 | Dupixent | $16 |
| Lilly USA | Meals · 2025-04-15 | Taltz | $29 |
| Ucb | Meals · 2025-04-15 | Bimzelx | $15 |
| Amgen | Meals · 2025-04-08 | Otezla | $27 |
| Incyte | Meals · 2025-04-07 | Opzelura | $16 |
| Abbvie | Meals · 2025-04-01 | Rinvoq | $25 |
| Ucb | Meals · 2025-04-01 | Bimzelx | $12 |
| Genzyme | Meals · 2025-04-01 | Dupixent | $40 |
| Abbvie | Meals · 2025-03-24 | Rinvoq | $27 |
| Incyte | Meals · 2025-03-20 | Opzelura | $22 |
| Galderma Laboratories L.P. | Meals · 2025-03-19 | Nemluvio | $20 |
| Arcutis Biotherapeutics | Meals · 2025-03-18 | Zoryve | $14 |
| Abbvie | Meals · 2025-03-12 | Skyrizi | $9 |
| Janssen Biotech | Meals · 2025-03-11 | Tremfya | $13 |
| Ucb | Meals · 2025-03-11 | Bimzelx | $16 |
| Amgen | Meals · 2025-03-11 | Otezla | $2 |
| Amgen | Meals · 2025-03-11 | Otezla | $16 |
| Galderma Laboratories L.P. | Meals · 2025-03-11 | Nemluvio | $23 |
| Abbvie | Meals · 2025-03-05 | Skyrizi | $12 |
| Regeneron Healthcare Solutions | Meals · 2025-03-04 | Dupixent | $14 |
| Arcutis Biotherapeutics | Meals · 2025-03-03 | Zoryve | $21 |
| Abbvie | Meals · 2025-02-21 | Skyrizi | $21 |
| Abbvie | Meals · 2025-02-21 | Skyrizi | $1 |
| Amgen | Meals · 2025-02-19 | Otezla | $89 |
| STRATA Skin Sciences | Meals · 2025-02-17 | Xtrac | $19 |
| Genzyme | Meals · 2025-02-13 | Dupixent | $28 |
| Ucb | Meals · 2025-02-11 | Bimzelx | $8 |
| Arcutis Biotherapeutics | Meals · 2025-02-11 | Zoryve | $12 |
| Genzyme | Meals · 2025-02-10 | Dupixent | $31 |
| Organon | Meals · 2025-02-10 | Vtama | $9 |
| Abbvie | Meals · 2025-02-05 | Skyrizi | $9 |
| Novartis Pharmaceuticals | Meals · 2025-01-29 | Cosentyx | $19 |
| Ucb | Meals · 2025-01-29 | Bimzelx | $9 |
| Arcutis Biotherapeutics | Meals · 2025-01-29 | Zoryve | $80 |
| Galderma Laboratories L.P. | Meals · 2025-01-28 | Nemluvio | $20 |
| Abbvie | Education · 2025-01-23 | None | $10 |
| Amgen | Meals · 2025-01-23 | Otezla | $14 |
| Abbvie | Meals · 2025-01-22 | Skyrizi | $7 |
| Regeneron Healthcare Solutions | Meals · 2025-01-22 | Dupixent | $15 |
| Incyte | Meals · 2025-01-22 | Opzelura | $9 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-01-21 | Siliq | $15 |
| Incyte | Meals · 2025-01-21 | Opzelura | $98 |
| Organon | Meals · 2025-01-21 | Vtama | $9 |
| Incyte | Meals · 2025-01-10 | Opzelura | $26 |
| Amgen | Meals · 2025-01-08 | Otezla | $26 |
| Regeneron Healthcare Solutions | Meals · 2025-01-07 | Dupixent | $26 |
| Amgen | Meals · 2025-01-07 | Otezla | $19 |
| Organon | Meals · 2025-01-07 | Vtama | $24 |
| Ucb | Meals · 2025-01-06 | Bimzelx | $11 |
See earlier years (2024, 2023, 2022, 2021)
2024: $3,487
| Incyte | Opzelura | $455 | 21 payments
|
| Abbvie | Skyrizi | $431 | 17 payments
|
| Regeneron Healthcare Solutions | Dupixent | $407 | 19 payments
|
| Janssen Biotech | Tremfya | $383 | 13 payments
|
| Dermavant Sciences | Vtama | $283 | 14 payments
|
| Sun Pharmaceutical Industries | Ilumya | $253 | 12 payments
|
| Novartis Pharmaceuticals | Cosentyx | $234 | 17 payments
|
| Genzyme | Dupixent | $217 | 8 payments
|
| Ortho Dermatologics a division of Bausch Health US | Cabtreo | $215 | 11 payments
|
| Lilly USA | Taltz | $198 | 7 payments
|
| Amgen | Otezla | $147 | 7 payments
|
| Arcutis Biotherapeutics | Zoryve | $67 | 4 payments
|
| Pfizer | Eucrisa | $40 | 2 payments
|
| Galderma Laboratories L.P. | None | $40 | 2 payments
|
| STRATA Skin Sciences | Xtrac | $31 | 1 payment
|
| LEO Pharma | Adbry | $25 | 1 payment
|
| Ucb | Bimzelx | $23 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $22 | 1 payment
|
| Teva Pharmaceuticals USA | Simlandi | $16 | 1 payment
|
2023: $2,060
| Sun Pharmaceutical Industries | Ilumya | $322 | 15 payments
|
| LEO Pharma | Adbry | $244 | 14 payments
|
| Incyte | Opzelura | $227 | 16 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $220 | 16 payments
|
| Lilly USA | Taltz | $207 | 20 payments
|
| Mayne Pharma Commercial | None | $126 | 13 payments
|
| Amgen | Otezla | $101 | 6 payments
|
| Abbvie | Rinvoq | $94 | 6 payments
|
| Genzyme | Dupixent | $86 | 5 payments
|
| Ucb | Cimzia | $86 | 5 payments
|
| Regeneron Healthcare Solutions | Dupixent | $74 | 5 payments
|
| Dermavant Sciences | Vtama | $65 | 4 payments
|
| Novartis Pharmaceuticals | Cosentyx | $65 | 3 payments
|
| Journey Medical | None | $37 | 2 payments
|
| Pfizer | Cibinqo | $30 | 2 payments
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $30 | 2 payments
|
| Janssen Biotech | Tremfya | $16 | 1 payment
|
| Arcutis Biotherapeutics | None | $16 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $15 | 1 payment
|
2022: $1,634
| LEO Pharma | Adbry | $188 | 11 payments
|
| Abbvie | Rinvoq | $184 | 12 payments
|
| Incyte | Opzelura | $172 | 11 payments
|
| Janssen Biotech | Tremfya | $170 | 6 payments
|
| EPI Health | Cloderm | $126 | 17 payments
|
| Lilly USA | Taltz | $118 | 9 payments
|
| Novartis Pharmaceuticals | Cosentyx | $86 | 6 payments
|
| Amgen | Otezla | $84 | 6 payments
|
| Ortho Dermatologics a division of Bausch Health US | Arazlo | $84 | 6 payments
|
| Pfizer | Eucrisa | $68 | 5 payments
|
| Genzyme | Dupixent | $57 | 3 payments
|
| Sun Pharmaceutical Industries | Blu-U | $54 | 4 payments
|
| Ucb | Cimzia | $46 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $40 | 3 payments
|
| Almirall | Seysara | $29 | 2 payments
|
| Journey Medical | Qbrexza | $28 | 2 payments
|
| Galderma Laboratories L.P. | Epsolay | $27 | 2 payments
|
| Nabriva Therapeutics plc | Sivextro | $27 | 2 payments
|
| Mayne Pharma | None | $18 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $15 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $14 | 1 payment
|
2021: $1,678
| Lilly USA | Taltz | $256 | 12 payments
|
| Janssen Biotech | Tremfya | $177 | 7 payments
|
| Galderma Laboratories L.P. | Aklief | $157 | 8 payments
|
| Ortho Dermatologics a division of Bausch Health US | Duobrii | $153 | 11 payments
|
| AbbVie | Skyrizi | $138 | 13 payments
|
| Novartis Pharmaceuticals | Cosentyx | $122 | 9 payments
|
| Regeneron Healthcare Solutions | Dupixent | $94 | 3 payments
|
| Ucb | Cimzia | $94 | 7 payments
|
| Sun Pharmaceutical Industries | Blu-U | $79 | 6 payments
|
| Genzyme | Dupixent | $67 | 5 payments
|
| VYNE Pharmaceuticals | Zilxi | $61 | 4 payments
|
| Pfizer | Eucrisa | $59 | 4 payments
|
| Amgen | Otezla | $56 | 4 payments
|
| LEO Pharma | Enstilar | $56 | 4 payments
|
| Incyte | Opzelura | $33 | 2 payments
|
| EPI Health | Cloderm | $27 | 2 payments
|
| PolarityTE | None | $17 | 1 payment
|
| Biofrontera | Ameluz | $15 | 1 payment
|
| Kyowa Kirin | Poteligeo | $15 | 1 payment
|
Professional record
- NPI
- 1306405030
- Licence
- CA 63162California A63162: Current · expires 2028-09-30
- Group
- Csi Medical Group
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 60 Pompton Ave, Verona, NJ, 07044
- NPI first listed
- 2019-06-06
- NPI last updated
- 2024-01-03
- NPI record certified
- 2024-01-03
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 9460 N Name Uno Ste 210, Gilroy, CA, 95020 · 60 Pompton Ave, Verona, NJ, 07044